SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $12,000 | -45.5% | 21,870 | -45.3% | 0.00% | 0.0% |
| Q1 2016 | $22,000 | -38.9% | 40,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $36,000 | +9.1% | 40,000 | -1.2% | 0.00% | +100.0% |
| Q3 2015 | $33,000 | -80.5% | 40,500 | -27.7% | 0.00% | -85.7% |
| Q2 2015 | $169,000 | +24.3% | 56,000 | +0.5% | 0.01% | +16.7% |
| Q1 2015 | $136,000 | -40.9% | 55,700 | -38.1% | 0.01% | -25.0% |
| Q4 2014 | $230,000 | – | 90,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |